Literature DB >> 1540418

Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation.

P N Fultz1, J C Gluckman, E Muchmore, M Girard.   

Abstract

Efficient replication and production of human immunodeficiency virus (HIV) has been shown to be influenced greatly not only by the activation state of the infected cell but also by a variety of cytokines. Thus, it seems reasonable to assume, as has been hypothesized, that any stimulus to the immune system, whether by intercurrent infection, exposure to new or recall antigens, or injury with inflammation, could enhance HIV expression in infected individuals. To test this hypothesis, we subjected an HIV-1-infected chimpanzee to repeated specific and nonspecific immune stimulation by inoculation of various vaccine preparations, adjuvant alone, or HIV-specific immune globulin. Transient increases both in numbers of infectious peripheral blood cells and in some HIV-specific immune responses occurred within 1 to 2 weeks after most inoculations, including administration of the immune globulin. These results have important implications for the use of immunotherapy as a treatment for HIV-infected persons and for immunization of HIV-infected infants and children against other pathogens. They suggest that both immunotherapy and vaccination of HIV-infected individuals should be accompanied by administration of an antiviral drug(s).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540418     DOI: 10.1089/aid.1992.8.313

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  11 in total

1.  Short communication: HIV type 1 accumulates in influenza-specific T cells in subjects receiving seasonal vaccination in the context of effective antiretroviral therapy.

Authors:  R Brad Jones; Colin Kovacs; Tae-Wook Chun; Mario A Ostrowski
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-14       Impact factor: 2.205

Review 2.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis.

Authors:  I C Davis; M Girard; P N Fultz
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus.

Authors:  Z W Chen; Y Shen; D Zhou; M Simon; Z Kou; D Lee-Parritz; L Shen; P Sehgal; N L Letvin
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Virus-specific cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected chimpanzees.

Authors:  S Santra; P N Fultz; N L Letvin
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS.

Authors:  Q Wei; P N Fultz
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees.

Authors:  K Saksela; E Muchmore; M Girard; P Fultz; D Baltimore
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

Authors:  R I Connor; H Mohri; Y Cao; D D Ho
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Activation of virus replication after vaccination of HIV-1-infected individuals.

Authors:  S I Staprans; B L Hamilton; S E Follansbee; T Elbeik; P Barbosa; R M Grant; M B Feinberg
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.